Evaluation of mantle cell lymphoma and methods related thereto

US11725248B2 · kind B2 · utility

Assignees

• The United States of America, as represented by the Secretary, Department of Health and Human Services · US
• British Columbia Cancer Agency Branch · CA
• Julius-Maximilians-Universitat Wurzburg · DE
• Oregon Health & Science University · US
• HOSPITAL CLÍNIC DE BARCELONA · ES
• UNIVERSITAT DE BARCELONA · ES
• Oslo University Hospital HF · NO
• The Cleveland Clinic Foundation · US
• Mayo Foundation for Medical Education and Research · US

Inventors

• Louis M. Staudt · Silver Spring, US
• David William Scott · Vancouver, CA
• George W. Wright · Rockville, US
• Andreas Rosenwald · Würzburg, DE
• Pau Abrisqueta · Barcelona, ES
• Rita M. Braziel · West Linn, US
• Elias Campo Guerri · Barcelona, ES
• Wing C. Chan · Pasadena, US
• Joseph M. Connors · Vancouver, CA
• Jan Delabie · Toronto, CA
• Diego Villa · Vancouver, CA
• Kai Fu · Omaha, US
• Randy D. Gascoyne · North Vancouver, CA
• Timothy C. Greiner · Gilliatt, US
• Elaine S. Jaffe · Great Falls, US
• Pedro Jares · Barcelona, ES
• Anja Mottok · Vancouver, CA
• German Ott · Bietigheim-Bissingen, DE
• Lisa M. Rimsza · Tucson, US
• Graham Slack · Richmond, CA
• Dennis Weisenburger · Glendora, US
• Erlend B. Smeland · Oslo, NO
• James Robert Cook · Shaker Heights, US

Key dates

• Filing date: Apr 20, 2017
• Grant date: Aug 15, 2023
• Expiry date: Nov 14, 2040

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q2600/158
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.